Statin therapy and cancer-specific mortality in Denmark

We don’t want to get into the details (which are covered extensively in other sources), but a study published today in the New England Journal of Medicine, and encompassing the entire population of Denmark, suggests that people with cancer who take a statin (a cholesterol-lowering agent) have a 15 percent lower mortality rate than cancer patients not taking a statin.

What this study still does not do (as noted in the accompanying editorial) is give us any idea of why one would see such a consequence in such a wide range of different cancers. For a little more detail about this study, please have a look at the Reuters report.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: